thymidine has been researched along with B-Cell Lymphoma in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intoxication due to insufficient renal clearance developed in 2 patients, a 54-year-old man and a 61-year-old woman, who were under treatment with methotrexate (MTX) for a primary cerebral lymphoma and a recurrence of large-cell B-cell-non-Hodgkin lymphoma, respectively." | 3.74 | [Management recommendations in patients with methotrexate intoxication]. ( Beijnen, JH; Schellens, JH, 2007) |
| "CD74 was expressed by most multiple myeloma cell lines, as was CD74 mRNA, at levels mirroring CD74 protein." | 1.32 | CD74 is expressed by multiple myeloma and is a promising target for therapy. ( Burton, JD; Cardillo, TM; Ely, S; Gold, DV; Goldenberg, DM; Reddy, PK; Stein, R, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montineri, A | 1 |
| Nigro, L | 1 |
| Chiarenza, A | 1 |
| Larocca, L | 1 |
| La Rosa, R | 1 |
| Iacobello, C | 1 |
| Di Raimondo, F | 1 |
| Fatuzzo, F | 1 |
| D'Costa, SS | 1 |
| Hurwitz, JL | 1 |
| Cittera, E | 1 |
| Onofri, C | 1 |
| D'Apolito, M | 1 |
| Cartron, G | 1 |
| Cazzaniga, G | 1 |
| Zelante, L | 1 |
| Paolucci, P | 1 |
| Biondi, A | 1 |
| Introna, M | 1 |
| Golay, J | 1 |
| Burton, JD | 1 |
| Ely, S | 1 |
| Reddy, PK | 1 |
| Stein, R | 1 |
| Gold, DV | 1 |
| Cardillo, TM | 1 |
| Goldenberg, DM | 1 |
| Acuña-Castillo, C | 1 |
| Aravena, M | 1 |
| Leiva-Salcedo, E | 1 |
| Pérez, V | 1 |
| Gómez, C | 1 |
| Sabaj, V | 1 |
| Nishimura, S | 1 |
| Pérez, C | 1 |
| Colombo, A | 1 |
| Walter, R | 1 |
| Sierra, F | 1 |
| Schmid, M | 1 |
| Neumaier, B | 1 |
| Vogg, AT | 1 |
| Wczasek, K | 1 |
| Friesen, C | 1 |
| Mottaghy, FM | 1 |
| Buck, AK | 1 |
| Reske, SN | 1 |
| Schellens, JH | 1 |
| Beijnen, JH | 1 |
| Zhou, HJ | 1 |
| Pham, LV | 1 |
| Tamayo, AT | 1 |
| Lin-Lee, YC | 1 |
| Fu, L | 1 |
| Yoshimura, LC | 1 |
| Ford, RJ | 1 |
| Schuster, C | 1 |
| Fernbach, N | 1 |
| Rix, U | 1 |
| Superti-Furga, G | 1 |
| Holy, M | 1 |
| Freissmuth, M | 1 |
| Sitte, HH | 1 |
| Sexl, V | 1 |
| Erikstein, BK | 1 |
| Holte, H | 1 |
| Kvaløy, S | 1 |
| Andersson, KB | 1 |
| Steen, HB | 1 |
| Hannisdal, E | 1 |
| Smeland, EB | 1 |
| Alama, A | 1 |
| Meazza, R | 1 |
| Barbieri, F | 1 |
| Biassoni, R | 1 |
| Mazzei, M | 1 |
| Nicolin, A | 1 |
| De Leon, M | 1 |
| Jackson, KM | 1 |
| Cavanaugh, JR | 1 |
| Mbangkollo, D | 1 |
| Verret, CR | 1 |
| Toomey, NL | 1 |
| Deyev, VV | 1 |
| Wood, C | 1 |
| Boise, LH | 1 |
| Scott, D | 1 |
| Liu, LH | 1 |
| Cabral, L | 1 |
| Podack, ER | 1 |
| Barber, GN | 1 |
| Harrington, WJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I/II Study of Immunotherapy With hLL1 Administered Twice Weekly for 4 Consecutive Weeks in Patients With Multiple Myeloma[NCT00421525] | Phase 1/Phase 2 | 25 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| A Phase I/II Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma[NCT01101594] | Phase 1/Phase 2 | 17 participants (Actual) | Interventional | 2010-07-31 | Terminated (stopped due to Study was terminated due to lack of efficacy) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 other studies available for thymidine and B-Cell Lymphoma
| Article | Year |
|---|---|
Telbivudine use in a patient affected by occult hepatitis B virus and B-cell non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
Phytohemagglutinin inhibits lymphoid tumor growth in vitro and in vivo.
Topics: Animals; Annexin A5; Antimetabolites, Antineoplastic; Apoptosis; Cell Cycle; Drug Combinations; Drug | 2003 |
Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; A | 2005 |
CD74 is expressed by multiple myeloma and is a promising target for therapy.
Topics: Animals; Antibodies, Monoclonal; Antigens, Differentiation, B-Lymphocyte; Cell Line, Tumor; Cell Pro | 2004 |
CD74 is expressed by multiple myeloma and is a promising target for therapy.
Topics: Animals; Antibodies, Monoclonal; Antigens, Differentiation, B-Lymphocyte; Cell Line, Tumor; Cell Pro | 2004 |
CD74 is expressed by multiple myeloma and is a promising target for therapy.
Topics: Animals; Antibodies, Monoclonal; Antigens, Differentiation, B-Lymphocyte; Cell Line, Tumor; Cell Pro | 2004 |
CD74 is expressed by multiple myeloma and is a promising target for therapy.
Topics: Animals; Antibodies, Monoclonal; Antigens, Differentiation, B-Lymphocyte; Cell Line, Tumor; Cell Pro | 2004 |
T-kininogen, a cystatin-like molecule, inhibits ERK-dependent lymphocyte proliferation.
Topics: Animals; Blotting, Western; Calcium; Cell Death; Cell Line, Tumor; Cell Proliferation; Concanavalin | 2005 |
Synthesis and evaluation of a radiometal-labeled macrocyclic chelator-derivatised thymidine analog.
Topics: Chelating Agents; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; HL-60 Cells; Humans; Indium | 2006 |
[Management recommendations in patients with methotrexate intoxication].
Topics: Antimetabolites, Antineoplastic; Brain Neoplasms; Female; Humans; Kidney; Leucovorin; Lymphoma; Lymp | 2007 |
Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma.
Topics: B-Cell Activating Factor; B-Lymphocytes; beta-Galactosidase; CD40 Antigens; Cell Nucleus; Cell Proli | 2007 |
Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia?
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Transformation, Neoplastic; Fibrob | 2007 |
Expression of CD18 (integrin beta 2 chain) correlates with prognosis in malignant B cell lymphomas.
Topics: Antigens, CD; CD18 Antigens; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Norway; Prognosis; | 1993 |
Antiproliferative effect of DNA polymerase alpha antisense oligodeoxynucleotides on breast cancer cells.
Topics: Adenocarcinoma; Base Sequence; Breast Neoplasms; Cell Division; DNA Polymerase II; DNA Replication; | 1993 |
Arrest of the cell cycle reduces susceptibility of target cells to perforin-mediated lysis.
Topics: Animals; Aphidicolin; Apoptosis; Cell Cycle; Cell Death; Cell Line; Cytoplasmic Granules; Cytotoxici | 1998 |
Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
Topics: Antimetabolites, Antineoplastic; Antiviral Agents; Apoptosis; Apoptosis Regulatory Proteins; Arabido | 2001 |